Foley Hoag is proud to sponsor Biopharm America, a part of Biotech Week Boston that is driving the future of drug development by bringing together the most innovative companies with leaders across the life science value chain.

Foley Hoag Partner and Life Sciences Practice co-chair Jeffrey Quillen will moderate a panel featuring biopharma experts and VC insiders, who will share their insights on how to navigate the Life Sciences venture landscape, which trends startups should watch for to help position their technologies, and the discoveries that attract investors.

Panel: Trends in Corporate VC Investment

In an effort to access cutting edge research and stay ahead of the curve during this unprecedented time, more investors and pharma companies are taking risks in working with very early stage companies. What long term trends have fizzled out and what is on the rise to mitigate the risk? did the global disruption set us back, or change the model temporarily? Are the new strategies sustainable as increasing investment rounds require more and more funds to obtain new treatments, therapies and technologies?

Leading biopharma experts and VCs will share their insights on how to navigate this landscape, which trends startupsshouldwatch for to help position their technologies and discoveries to attract investors.

Register